Invesaro

Stocks VRSK Financial statements

Financial statements

Verisk Analytics, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Verisk Analytics, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,9952,1452,3952,6072,2692,4632,4972,6812,8823,073
Cost of revenue714784886977792854825877901926
Gross profit1,2811,3611,5091,6301,4781,6091,6721,8051,9812,147
Research and development27.437.445.16044.647.143.136.835.340.9
Selling, general and administrative302323379604308313382392409458
Operating income7688018346979569111,4071,1321,2541,344
Interest expense120119130127138127139116125171
Other non-operating income-114-110-114-129-138-125-144-105-25.3-173
Pre-tax income6546917205688187871,2621,0271,2291,171
Income tax202136121119165179220259278263
Income from continuing operations4525555996546071,042768951908
Net income to minority interests000.10.4-0.2-0.70
Net income591555599450713666954615958908
EBITDA8949379998831,1491,1181,6041,3391,4881,603
EPS, basic3.513.363.632.754.384.126.044.196.746.50
EPS, diluted3.453.293.562.704.314.086.004.176.716.48
Shares, basic (weighted)168165165164163162158147142140
Shares, diluted (weighted)171169168167165163159147143140

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents1351421401852191121133032912,178
Receivables264346356442432300290334434422
Other current assets20.342.950.717.836.431.43265.229.930
Total current assets5015986457457949079258109122,765
Property, plant and equipment380478556548632531542605606583
Lease right-of-use assets0219268224182192156139
Goodwill2,5783,3693,3623,8641,8212,0481,6761,7611,7271,878
Intangible assets1,0111,3451,2281,3991,385482505472392347
Other non-current assets14621599.5160366409371496438447
Total assets4,6316,0205,9007,0557,5627,8086,9614,3664,2656,196
Accounts payable184225251375407262293341250319
Accrued liabilities88.6115131147159143117149144144
Deferred revenue331385383440467348322375447444
Short-term debt1077246734995149711,39314.55141,509
Total current liabilities6221,3381,3251,4921,4311,8482,3197711,2392,300
Long-term debt2,2802,2842,0512,6522,7002,3432,3432,8522,5473,228
Lease liabilities0208272231190196159137
Other non-current liabilities74.813575.748.864.743.317.914.623.626.8
Total liabilities3,2994,0953,8304,7944,8644,9665,1934,0444,1605,886
Total debt2,2772,2812,7423,1533,2253,3243,7442,8843,0914,774
Paid-in capital2,1222,1802,2832,3692,4912,6092,7212,8722,9943,113
Retained earnings2,7533,3083,9434,2284,7625,2405,9996,4177,1537,811
Treasury stock-2,891-3,151-3,563-3,850-4,179-4,638-6,240-9,038-10,062-10,722
Other comprehensive income-651-412-592-487-376-395-73158.215107
Shareholders' equity1,3321,9252,0712,2612,6982,8171,749310100309
Minority interests02618.412.24.90.8
Total equity1,3321,9252,0712,2612,6982,8431,768322105310
Total liabilities and equity4,6316,0205,9007,0557,5627,8086,9614,3664,2656,196
Shares outstanding167165164163163162155143140138

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income591555599450713666954614958908
Depreciation and amortization126136165186192207197207234259
Stock-based compensation3031.838.542.747.655.756.55447.954.2
Deferred income tax2.9-73.618.8-27.425.533.1-93.3-29-20.54.6
Change in receivables-5.7-45.5-17.4-70.31.8-29.7-57.7-83-117-1.3
Change in payables-2.628.558.115124.3-80.8-21.246.5-60.847.9
Cash from operations5787449349561,0681,1561,0591,0611,1441,436
Capital expenditures-157-184-231-217-247-268-275-230-224-244
Acquisitions-67.7-873-138-699-276-290-449-83.3
Purchases of investments0-0.300-94.8-23.6-46-2.2-1
Cash from investing493-1,106-265-928-596-5923012,747-125-358
Debt issued00062049500495590698
Debt repaid000-2500
Stock issued0087.352.48884.313314212556.9
Share buybacks-327-276-439-300-349-475-1,663-2,762-1,005-624
Dividends paid00-164-176-188-195-197-221-251
Cash from financing-1,064363-67010.9-445-499-1,330-3,787-1,029795
Exchange rate effect-9.76.7-26.17-3.3-17.8-10.7-2.213.9
Net change in cash-3.27.2-2.845.128061.512.410-11.51,887
Free cash flow4215607037408218877848319201,192
Interest paid117114125120134129134111132150
Income taxes paid289186103140157175325276288218

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $169.21 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin70.0%Gross profit / revenue.
Operating margin44.0%Operating income / revenue.
EBITDA margin52.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin38.1%Pre-tax income / revenue.
Net margin29.3%Net income / revenue.
FCF margin36.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin44.5%Cash from operations / revenue.
Effective tax rate23.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)19.8%Net income / average total assets.
Return on invested capital (ROIC)41.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue14.8%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue8.2%Capital expenditures / revenue.
D&A / revenue8.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y7.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y6.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y8.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y8.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y7.8%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y7.2%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-1.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y7.0%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y7.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-0.0%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y6.9%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-5.2%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-1.6%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y5.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-3.4%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y2.6%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y8.5%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y25.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y10.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y6.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y29.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y15.0%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y7.7%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y208.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-43.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-35.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y45.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-3.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-3.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.9%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-4.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-3.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.02xCurrent assets / current liabilities.
Quick ratio0.91x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.44x(Cash + short-term investments) / current liabilities.
Debt / assets91.7%Total debt / total assets.
Liabilities / assets125.4%Total liabilities / total assets.
Net debt$3.69BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.27xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage7.68xOperating income / interest expense.
Working capital$21.2MCurrent assets - current liabilities.
Goodwill and intangibles / assets47.7%(Goodwill + intangible assets) / total assets.
Tangible book value-$3.36BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.67xRevenue / average total assets.
Fixed asset turnover5.37xRevenue / average property, plant and equipment.
Receivables turnover5.60xRevenue / average receivables.
Days sales outstanding65 days365 x average receivables / revenue.
Days payables78 days365 x average accounts payable / cost of revenue.
FCF conversion123.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow18.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$6.73Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$22.94Revenue / diluted weighted shares.
FCF per share$8.34Free cash flow / diluted weighted shares.
Operating cash flow per share$10.22Cash from operations / diluted weighted shares.
Book value per share-$8.91Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$25.64Tangible book value / shares outstanding.
Cash per share$4.00(Cash + short-term investments) / shares outstanding.
Payout ratio27.9%Dividends paid / net income, when net income is positive.
Dividends / FCF22.5%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF162.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$22.02BShare price x shares outstanding.
Enterprise value$25.72BMarket cap + total debt - cash - short-term investments.
P/E24.2xMarket cap / net income. Only when net income is positive.
P/S7.10xMarket cap / revenue.
P/FCF19.5xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.9xMarket cap / cash from operations, when positive.
EV/Sales8.29xEnterprise value / revenue.
EV/EBIT18.8xEnterprise value / operating income, when both are positive.
EV/EBITDA15.8xEnterprise value / EBITDA, when both are positive.
EV/FCF22.8xEnterprise value / free cash flow, when both are positive.
FCF yield5.1%Free cash flow / market cap.
Earnings yield4.1%Net income / market cap (the inverse of P/E).
Dividend yield1.2%Dividends paid over the period / market cap.
Shareholder yield9.4%(Dividends paid + share buybacks) / market cap.
PEG9.31xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Verisk Analytics, Inc.'s revenue in fiscal 2025?

Verisk Analytics, Inc. reported revenue of $3.07B for fiscal 2025, 6.6% higher than the year before.

Was Verisk Analytics, Inc. profitable in fiscal 2025?

Yes. Net income was $908.3M, a net margin of 29.6%.

How much free cash flow did Verisk Analytics, Inc. generate in fiscal 2025?

Cash from operations of $1.44B minus capital expenditures of $244.1M left free cash flow of $1.19B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Verisk Analytics, Inc.